Infliximab, a TNF-α antibody, increased both muscle volume and strength in CD patients [106], and moreover, colectomy increased SMI and serum albumin with a decrease in the prevalence of sarcopenia in UC patients [45]. The gene discussed is TNF; the disease is sarcopenia.